Congenital nephrogenic diabetes insipidus treated with acetazolamide.

Nephrology (Carlton)

Division of Nephrology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.

Published: July 2024

Congenital nephrogenic diabetes insipidus (CNDI) is a rare disorder. The condition is characterised by an inability of distal nephron segments to respond to normal or raised concentrations of serum antidiuretic hormone. In this report, we describe the case of a 13-year-old male known with CNDI who experienced a pedestrian vehicle accident leading to coma following a head injury. Intra-operatively, severe hypernatraemia and polyuria were observed. Following an inadequate response to conventional therapy, acetazolamide was prescribed resulting in an immediate response to therapy. To the best of our knowledge, acetazolamide has not been previously documented as a therapeutic option for CNDI. Additional research is necessary before considering the recommendation of acetazolamide for cases of NDI that do not respond adequately to conventional treatments.

Download full-text PDF

Source
http://dx.doi.org/10.1111/nep.14291DOI Listing

Publication Analysis

Top Keywords

congenital nephrogenic
8
nephrogenic diabetes
8
diabetes insipidus
8
insipidus treated
4
acetazolamide
4
treated acetazolamide
4
acetazolamide congenital
4
insipidus cndi
4
cndi rare
4
rare disorder
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!